SCHEMBL6756935

SCHEMBL6756935

Cc1ncn(-c2cc(N)cc(Cl)c2)c1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
HIF1A Q16665 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP11B2 P19099 1/20 0.35
MKNK1 Q9BUB5 1/20 0.34
MKNK2 Q9HBH9 1/20 0.34
HCAR1 Q9BXC0 1/20 0.32
PDE3B Q13370 1/20 0.32
PDE3A Q14432 1/20 0.32
PTGS2 P35354 2/20 0.31
PTGS1 P23219 1/20 0.31
NR2E1 Q9Y466 1/20 0.31
FGFR1 P11362 1/20 0.30
ALOX15 P16050 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6756743 0.78 ALDH1A1 (0.43) ALDH1A1HPGDCYP1A2CYP2D6HIF1A
SCHEMBL6756829 0.76 ALDH1A1 (0.37) ALDH1A1HPGDCYP1A2CYP2D6HIF1A
SCHEMBL6757787 0.75 ALDH1A1 (0.49) ALDH1A1HPGDCYP1A2CYP2D6HIF1A
SCHEMBL19214262 0.73 ALDH1A1 (0.50) ALDH1A1HPGDCYP1A2CYP2D6HIF1A
SCHEMBL22143673 0.73 MKNK1 (0.52) ALDH1A1HPGDCYP1A2CYP2D6HIF1A
SCHEMBL6754277 0.69 ALDH1A1 (0.42) ALDH1A1HPGDCYP1A2CYP2D6HIF1A
SCHEMBL6757847 0.66 ALDH1A1 (0.46) ALDH1A1MKNK1MKNK2HCAR1FGFR1
SCHEMBL30899602 0.66 ALDH1A1 (0.46) ALDH1A1HPGDCYP1A2CYP2D6HIF1A
SCHEMBL29205263 0.66 ALDH1A1 (0.46) ALDH1A1HPGDCYP1A2CYP2D6HIF1A
SCHEMBL9288138 0.65 ALDH1A1 (0.53) ALDH1A1HPGDCYP1A2CYP2D6HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040087798-A1 Novel amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-05-06 US disclosed
EP-1264820-A1 NOVEL AMIDE COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-12-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087798-A1 Novel amide compounds H1-2, H1-0, H1-3 ALDH1A1 1144/4885HPGD 1663/4885CYP1A2 1021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.